Načítá se...
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
Mineralocorticoid-receptor antagonists (MRAs) have proven to be effective in some types of hypertension, especially in resistant hypertension (RHTN). In this phenotype of hypertension, the renin–angiotensin–aldosterone pathway plays an important role, with MRAs being especially effective in reducing...
Uloženo v:
| Vydáno v: | Vasc Health Risk Manag |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652936/ https://ncbi.nlm.nih.gov/pubmed/29081661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S138599 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|